期刊文献+

肝癌相关肿瘤抗原AFP新的HLA-A2/A24限制性CTL表位的预测及分析

Prediction and analysis of a novel HLA-A2/A24-restricted CTL epitope derived from AFP antigen associated with hepatocellular carcinoma
下载PDF
导出
摘要 目的:预测肝癌肿瘤抗原AFP新的HLA-A2/A24限制性CTL表位,为肝癌CTL表位肽的筛选及鉴定提供依据。方法:选择与肝癌密切相关的肿瘤抗原AFP为研究目标,采用NetCTL1.2Server远程预测系统进行HLA-A2/A24限制性CTL表位预测。结果:共预测出与肝癌相关的肿瘤相关抗原AFP的8个HLA-A2限制性CTL表位,13个HLA-A24限制性CTL表位。结论:应用NetCTL1.2Server法预测CTL表位是一种高效准确的预测方法。所预测的肿瘤抗原AFP的HLA-A2/24限制性CTL表位经实验筛选、鉴定后,可为肝癌治疗性疫苗的制备选择合适的CTL表位提供依据。 Objective : To predict the HLA - A2/A24 restricted CTL epitopes of antigen AFP, associated with hepatocellular carcinoma (HCC), so as to provide appropriate CTL epitope for hepatocellular carcinoma. Methods: HLA - A/A24 - restricted CTL epitopes of antigen AFP were predicted with NetCTL1.2 Server on web, COMB 〉 1.0. Results: Eight HLA - A2 and thirteen HLA - A24 restricted CTL epitope candidates (nonamers) derived from the tumor antigen AFP associated with HCC were predicted. Conclusion: NetCTL 1.2 Server prediction method improve the prediction efficiency and accuracy. These nonamers, after identified by experiment will be useful to develop promising antigen peptide tumor vaccines for HCC.
出处 《现代肿瘤医学》 CAS 2009年第10期1839-1842,共4页 Journal of Modern Oncology
基金 国家高技术研究发展计划项目("863"计划)(编号:2007AA02Z470) 陕西省攻关项目[编号:2007K09-05(2)]
关键词 甲胎蛋白 HLA—A2/A24抗原 细胞毒性T淋巴细胞表位 预测 AFP HLA - A2/A24 antigen cytotxic T lymphocyte epitope prediction
  • 相关文献

参考文献9

  • 1Butterfield LH, Meng WS, Koh A, et al. T cell responses to HLA - A * 0201 - restricted peptides derived from human ct fetoprotein [ J]. J Immunol,2001,15 ( 166 ) :5300 - 5308.
  • 2Bhasin M, Raghava GP. A hybrid approach for predicting promiscuous MHC class I restricted T cell epitopes[ J]. J Biosci,2007,32 (1) :31 -42.
  • 3Kesmir C, Nussbaum AK, Schild H, et al. Prediction of pmteasome cleavage motifs by neural networks [ J ]. Protein Eng, 2002, 15 (4) :287 -296.
  • 4Daniel S, Brusic V, Caillat Zucman S, et al. Relationship between peptide selectivities of human transporters associated with antigen processing and HLA class I molecules [ J]. J Immunol, 1998,161 (2) :617 -624.
  • 5Cascio P, Hilton C, Kisselev AF, et al. 26S proteasomes and immuno - proteasomes produce mainly Noextended versions of anantigenic peptide [ J]. EMBOJ,2001,20 (10) :2357 - 2366.
  • 6汤旭东,房殿春,万瑛,杨仕明.CTL表位预测的研究进展[J].实用临床医药杂志,2008,12(1):31-37. 被引量:3
  • 7Butterfield LH, Ribas A, Dissette VB, et al. A phase I/ II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha - fetoprotein peptides [ J ]. Clin Cancer Res,2006,12 : 2817 - 2825.
  • 8Geissler M, Molar L, Dohler G, et al. Immunotherapy directed against alpha - fetoprotein results in autoimmune liver disease during liver regeneration in mice [ J]. Gastroenterology, 2001,121 : 931 - 939.
  • 9Butterfield LH, Ribas A, Meng WS, et al. T2 cell responses to HLA - A3 0201 immunodominant peptides derived from alpha - fetoprotein in patients with hepatoceUular cancer [ J]. Clin Cancer Res, 2003,9:5902 - 5908.

二级参考文献47

  • 1Baldi P, Brunak S. Bioinformatics, the machine learning approach[ M]. MIT Press Cambrige Massachusetts, Londen England, 1998.
  • 2Rost B, Sander C. Prediction of protein secondary structure at better than 70 % accuracy[ J ]. J Mol Biol, 1993,232 (2) : 584.
  • 3Donnes P, and Elofsson A. Prediction of MHC class I binding peptides, using S MHC[J]. BMC Bioinform, 2002, 3 (1): 25.
  • 4Brusic V, Bajic V B, Petrovsky N. Computational methods for prediction of T-cell epitopes-a framework for modelling, testing, and applications[J]. Methods, 2004, 34(4): 436.
  • 5Bui H H, Schiewe A J, von Grafenstein H, Haworth I S. Structural prediction of peptides binding to MHC class I molectdes[J]. Proteins, 2006, 63(1): 43.
  • 6Fagerberg T, Cerottini J C, Michielin O. Structural prediction of peptides bound to MHC class I[J]. J Mol Biol, 2006, 356(2) : 521.
  • 7Sander O, Sommer I, Lengauer T. Local protein structure prediction using discriminative models [ J ]. BMC Bioinformatics, 2006, 7(1): 14.
  • 8Madden D R. The three-dimensional structure of peptide- MHC complexes[J]. Annu Rev Immunol, 1995, 13 (1):587.
  • 9Sehueler Furman O, Altuvia Y, Sette A, Margalit H. Structure-based prediction of binding peptides to MHC class I molecules:application to a broad range of MHC alleles[J]. Protein Sci, 2000, 9(9) ." 1838.
  • 10Doytchinova I A, Flower D R. Physicochemical explanation of peptide binding to HLA-A * 0201 major histocompatibility complex: a three-dimensional quantitative structure-activity relationship study[J]. Proteins, 2002, 48(3): 505.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部